Treatment of Pneumonia in Geriatric Patients with Normal Kidney Function

Initial Assessment and Treatment Selection

The American Thoracic Society recommends determining severity using tools like CURB-65 to guide treatment setting and antibiotic choice 2, 3
Non-severe pneumonia can often be treated with oral antibiotics, as recommended by the British Thoracic Society 2
Severe pneumonia requires immediate parenteral (IV) antibiotics, according to the British Thoracic Society 2

The British Thoracic Society recommends first-line therapy with combined oral therapy with amoxicillin and a macrolide (erythromycin or clarithromycin) for hospitalized patients with non-severe community-acquired pneumonia (CAP) 2
The British Thoracic Society suggests alternative therapy with monotherapy with a macrolide or a respiratory fluoroquinolone (levofloxacin) for penicillin-allergic patients with non-severe CAP 2
The British Thoracic Society recommends first-line therapy with intravenous combination of a broad-spectrum β-lactamase stable antibiotic (co-amoxiclav, cefuroxime, cefotaxime, or ceftriaxone) plus a macrolide (clarithromycin or erythromycin) for severe community-acquired pneumonia 2, 4

The British Thoracic Society recommends 7 days of appropriate antibiotics for non-severe and uncomplicated pneumonia 4
The British Thoracic Society suggests 10 days of treatment for severe microbiologically undefined pneumonia 4
The Infectious Diseases Society of America recommends extended treatment (14-21 days) when legionella, staphylococcal, or gram-negative enteric bacilli pneumonia are suspected or confirmed 1
Patients should be treated for a minimum of 5 days, should be afebrile for 48-72 hours, and should have no more than one CAP-associated sign of clinical instability before discontinuation of therapy, as recommended by the Infectious Diseases Society of America 1

The European Respiratory Society recommends reviewing clinical response daily, including temperature, respiratory and hemodynamic parameters 3
The British Thoracic Society suggests considering further investigations including repeat chest radiograph, CRP, white cell count, and additional microbiological testing for patients who fail to improve as expected 2

The British Thoracic Society recommends influenza vaccination for all geriatric patients, especially those with chronic lung, heart, renal, liver disease, diabetes mellitus, or immunosuppression 4
The British Thoracic Society suggests pneumococcal vaccination for all those aged 2 years or older in whom pneumococcal infection is likely to be more common or serious 4

The British Thoracic Society recommends monitoring for C. difficile-associated diarrhea, particularly with broad-spectrum antibiotics 2
The British Thoracic Society suggests clinical review should be arranged for all patients at around 6 weeks, with a chest radiograph for those with persistent symptoms or physical signs or who are at higher risk of underlying malignancy 2